259 related articles for article (PubMed ID: 37419119)
1. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.
Wang R; Song S; Qin J; Yoshimura K; Peng F; Chu Y; Li Y; Fan Y; Jin J; Dang M; Dai E; Pei G; Han G; Hao D; Li Y; Chatterjee D; Harada K; Pizzi MP; Scott AW; Tatlonghari G; Yan X; Xu Z; Hu C; Mo S; Shanbhag N; Lu Y; Sewastjanow-Silva M; Fouad Abdelhakeem AA; Peng G; Hanash SM; Calin GA; Yee C; Mazur P; Marsden AN; Futreal A; Wang Z; Cheng X; Ajani JA; Wang L
Cancer Cell; 2023 Aug; 41(8):1407-1426.e9. PubMed ID: 37419119
[TBL] [Abstract][Full Text] [Related]
2. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
4. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
5. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
7. Comparative single-cell analysis reveals heterogeneous immune landscapes in adenocarcinoma of the esophagogastric junction and gastric adenocarcinoma.
Chen J; Huang Q; Li YQ; Li Z; Zheng J; Hu W; Yang Y; Wu D; Bei JX; Gu B; Wang J; Li Y
Cell Death Dis; 2024 Jan; 15(1):15. PubMed ID: 38182569
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment.
Sathe A; Grimes SM; Lau BT; Chen J; Suarez C; Huang RJ; Poultsides G; Ji HP
Clin Cancer Res; 2020 Jun; 26(11):2640-2653. PubMed ID: 32060101
[TBL] [Abstract][Full Text] [Related]
9. The immune microenvironment in gastric adenocarcinoma.
Zavros Y; Merchant JL
Nat Rev Gastroenterol Hepatol; 2022 Jul; 19(7):451-467. PubMed ID: 35288702
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
Suzuki J; Tsuboi M; Ishii G
Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
[TBL] [Abstract][Full Text] [Related]
11. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
[No Abstract] [Full Text] [Related]
13. Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles.
Grunberg N; Pevsner-Fischer M; Goshen-Lago T; Diment J; Stein Y; Lavon H; Mayer S; Levi-Galibov O; Friedman G; Ofir-Birin Y; Syu LJ; Migliore C; Shimoni E; Stemmer SM; Brenner B; Dlugosz AA; Lyden D; Regev-Rudzki N; Ben-Aharon I; Scherz-Shouval R
Cancer Res; 2021 Apr; 81(7):1639-1653. PubMed ID: 33547159
[TBL] [Abstract][Full Text] [Related]
14. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
15. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
Fan Y; Li Y; Yao X; Jin J; Scott A; Liu B; Wang S; Huo L; Wang Y; Wang R; Pool Pizzi M; Ma L; Shao S; Sewastjanow-Silva M; Waters R; Chatterjee D; Liu B; Shanbhag N; Peng G; Calin GA; Mazur PK; Hanash SM; Ishizawa J; Hirata Y; Nagano O; Wang Z; Wang L; Xian W; McKeon F; Ajani JA; Song S
Gut; 2023 Apr; 72(4):624-637. PubMed ID: 36002248
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer.
Wang J; Akter R; Shahriar MF; Uddin MN
Pathol Oncol Res; 2022; 28():1610350. PubMed ID: 35991839
[No Abstract] [Full Text] [Related]
17. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
[TBL] [Abstract][Full Text] [Related]
18. DZIP1 expressed in fibroblasts and tumor cells may affect immunosuppression and metastatic potential in gastric cancer.
Yin Y; Liu Y; Wang Y; Li J; Liang S; Zhang W; Ma Z; Liu S; Zou X
Int Immunopharmacol; 2023 Apr; 117():109886. PubMed ID: 36805200
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma.
Liu X; Xu C; Guo T; Zhan S; Quan Q; Li M; Wang Z; Zhang X; Guo L; Cao L
Front Immunol; 2023; 14():1173524. PubMed ID: 37441080
[TBL] [Abstract][Full Text] [Related]
20. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.
Li Y; Fan Y; Xu J; Huo L; Scott AW; Jin J; Yang B; Shao S; Ma L; Wang Y; Yao X; Pool Pizzi M; Sewastjanow Da Silva M; Zhang G; Zhuo L; Cho EJ; Dalby KN; Shanbhag ND; Wang Z; Li W; Song S; Ajani JA
J Exp Clin Cancer Res; 2022 Aug; 41(1):257. PubMed ID: 35996148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
